SCHEMBL533022

SCHEMBL533022

Cc1cc(C)c(N2CCCC2)c(C)c1NC(=O)c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
MAPK1 P28482 1/20 0.52
HSD17B10 Q99714 1/20 0.52
MAPT P10636 2/20 0.51
KDM4E B2RXH2 1/20 0.51
NPC1 O15118 4/20 0.49
RAB9A P51151 4/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
MAPK14 Q16539 1/20 0.49
NR1H4 Q96RI1 1/20 0.48
CASP3 P42574 2/20 0.47
SENP7 Q9BQF6 2/20 0.47
TAAR1 Q96RJ0 1/20 0.47
CYP1A2 P05177 1/20 0.47
GAA P10253 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
RXFP1 Q9HBX9 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL532849 0.85 SMN1; SMN2 (0.49) MEN1KMT2AHSD17B10MAPTKDM4E
SCHEMBL532963 0.84 SGMS2 (0.52) MEN1KMT2ANPC1SMN1; SMN2GAA
SCHEMBL532794 0.81 POLB (0.45) MEN1KMT2AMAPTKDM4ENPC1
SCHEMBL532995 0.80 NPC1 (0.54) MEN1KMT2AMAPK1MAPTKDM4E
SCHEMBL532967 0.80 RAB9A (0.57) MEN1KMT2AMAPTKDM4ENPC1
SCHEMBL533966 0.78 POLB (0.44) MEN1KMT2AMAPK1MAPTKDM4E
SCHEMBL533054 0.77 MAPT (0.45) MEN1KMT2AMAPK1MAPTKDM4E
SCHEMBL532946 0.77 KCNQ2 (0.53) MEN1KMT2AMAPK1MAPTKDM4E
SCHEMBL534049 0.77 SCN9A (0.47) MEN1KMT2AMAPK1MAPTKDM4E
SCHEMBL534076 0.75 POLB (0.53) MEN1KMT2AMAPK1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
WO-2004073634-A2 PHENYLENEDIAMINE UROTENSIN-II RECEPTOR ANTAGONISTS AND CCR-9 ANTAGONISTS ENCYSIVE PHARMACEUTICALS INC. (US) 2004-09-02 WO disclosed